Chapter 9: Healthcare Expenditures for Persons with ESRD

Slides:



Advertisements
Similar presentations
Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Advertisements

Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 6: Medicare Expenditures for CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Stages of CKD – KDOQI 2002 Definitions
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 14: End-of-life Care for Patients with End-Stage Renal Disease:
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
Chapter 6: Medicare Expenditures for Persons with CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 12: Part D Prescription Drug Coverage in Patients with ESRD.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
2016 Annual Data Report, Vol 2, ESRD, Ch 13
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
2016 Annual Data Report, Vol 2, ESRD, Introduction
UK Renal Registry 13th Annual Report
Figure 11.1 Trends in ESRD expenditures,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Table 6.1 Prevalent Medicare fee-for-service patient counts and spending for beneficiaries aged 65 and older, by DM, CHF, and/or CKD, 2014 U.S. Medicare.
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Chapter 2: Identification and Care of Patients With CKD
Volume 2: End-Stage Renal Disease
Chapter 8: Cardiovascular Disease in Patients with ESRD
2017 Annual Data Report Healthy People 2020.
Chapter 6: Health Expenditures for Persons with CKD
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 12: End-of-life Care for Patients with ESRD:
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
December 31st point prevalent counts by modality figure 3.1
2016 Annual Data Report, Vol 2, ESRD, Ch 4
2016 Annual Data Report, Vol 2, ESRD, Ch 12
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Chapter 2: Clinical Indicators and Preventive Care
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
2016 Annual Data Report, Vol 1, CKD, Ch 3
Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Chapter 9: Healthcare Expenditures for Persons with ESRD
Chapter 2: Identification and Care of Patients with CKD
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 12: End-of-life Care for Patients with ESRD:
Chapter 7: Healthcare Expenditures for Persons with CKD
UK Renal Registry 16th Annual Report
In Reply to ‘The US Renal Data System “Pie Chart of Death”’
New ESRD Patients and Main Sources
A Timely Evaluation of the Psychometric Properties of the KDQOL-36
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Worldwide incidence of ESRD figure 12.1, per million population
Figure 9.1.a Causes of death in ESRD patients,
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

Chapter 9: Healthcare Expenditures for Persons with ESRD 2017 Annual Data Report Volume 2: End-Stage Renal Disease Chapter 9: Healthcare Expenditures for Persons with ESRD

vol 2 Figure 9.1 Trends in ESRD expenditures, 2004-2015 Data Source: USRDS ESRD Database; Reference Table K.1. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.2 Trends in costs of the Medicare & ESRD programs, 2004-2015 Data Source: Total ESRD costs obtained from USRDS ESRD Database; Reference Table K.1. Total Medicare expenditures obtained from Trustees Report, Table II.B1 https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/TrusteesReports.html. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.3 Trends in numbers of point prevalent ESRD patients, 2004-2015 Data Source: USRDS ESRD Database. December 31 point prevalent ESRD patients. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.4 Annual percent change in Medicare ESRD spending, 2004-2015 Data Source: USRDS ESRD Database; Reference Table K.4. Total Medicare ESRD costs from claims data; includes all claims with Medicare as primary payer only. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.5 Trends in total Medicare fee-for-service spending for ESRD, by type of service, 2004-2015 Data Source: USRDS ESRD Database; Reference Table K.1. Total Medicare costs from claims data. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.6 Total Medicare fee-for-service inpatient spending by cause of hospitalization, 2004-2015 Data Source: USRDS ESRD Database. Total Medicare costs from claims data for period prevalent ESRD patients. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.7 Total Medicare ESRD expenditures, by modality, 2004-2015 Data Source: USRDS ESRD Database. Total Medicare costs from claims data for period prevalent ESRD patients. Abbreviation: ESRD, end-stage renal disease.

vol 2 Figure 9.8 Total Medicare ESRD expenditures per person per year, by modality, 2004-2015 Data Source: USRDS ESRD Database; Reference Tables K.7, K.8, & K.9. Period prevalent ESRD patients; includes all claims with Medicare as primary payer only. Abbreviation: ESRD, end-stage renal disease.